ID   MINP1_HUMAN             Reviewed;         487 AA.
AC   Q9UNW1; F5H683; O95172; O95286; Q59EJ2; Q9UGA3;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 146.
DE   RecName: Full=Multiple inositol polyphosphate phosphatase 1 {ECO:0000312|HGNC:HGNC:7102};
DE            EC=3.1.3.62 {ECO:0000269|PubMed:18413611};
DE   AltName: Full=2,3-bisphosphoglycerate 3-phosphatase {ECO:0000303|PubMed:18413611};
DE            Short=2,3-BPG phosphatase {ECO:0000303|PubMed:18413611};
DE            EC=3.1.3.80 {ECO:0000269|PubMed:18413611};
DE   AltName: Full=Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase;
DE            Short=Ins(1,3,4,5)P(4) 3-phosphatase;
DE   Flags: Precursor;
GN   Name=MINPP1; Synonyms=MIPP; ORFNames=UNQ900/PRO1917;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF HIS-370.
RX   PubMed=9923613; DOI=10.1016/S0014-5793(98)01636-6;
RA   Caffrey J.J., Hidaka K., Matsuda M., Hirata M., Shears S.B.;
RT   "The human and rat forms of multiple inositol polyphosphate
RT   phosphatase: functional homology with a histidine acid phosphatase up-
RT   regulated during endochondral ossification.";
RL   FEBS Lett. 442:99-104(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10087200; DOI=10.1006/geno.1998.5736;
RA   Chi H., Tiller G.E., Dasouki M.J., Romano P.R., Wang J., O'keefe R.J.,
RA   Puzas J.E., Rosier R.N., Reynolds P.R.;
RT   "Multiple inositol polyphosphate phosphatase: evolution as a distinct
RT   group within the histidine phosphatase family and chromosomal
RT   localization of the human and mouse genes to chromosomes 10q23 and
RT   19.";
RL   Genomics 56:324-336(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INVOLVEMENT IN NMTC2, AND VARIANTS NMTC2 LEU-41 AND ARG-270.
RX   PubMed=11297621; DOI=10.1210/jcem.86.4.7419;
RA   Gimm O., Chi H., Dahia P.L., Perren A., Hinze R., Komminoth P.,
RA   Dralle H., Reynolds P.R., Eng C.;
RT   "Somatic mutation and germline variants of MINPP1, a phosphatase gene
RT   located in proximity to PTEN on 10q23.3, in follicular thyroid
RT   carcinomas.";
RL   J. Clin. Endocrinol. Metab. 86:1801-1805(2001).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-242.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [11]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16759730; DOI=10.1016/j.jbiotec.2006.04.028;
RA   Cho J., Choi K., Darden T., Reynolds P.R., Petitte J.N., Shears S.B.;
RT   "Avian multiple inositol polyphosphate phosphatase is an active
RT   phytase that can be engineered to help ameliorate the planet's
RT   'phosphate crisis'.";
RL   J. Biotechnol. 126:248-259(2006).
RN   [12]
RP   FUNCTION AS 2,3-BISPHOSPHOGLYCERATE 3-PHOSPHATASE, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND MUTAGENESIS OF HIS-89.
RX   PubMed=18413611; DOI=10.1073/pnas.0710980105;
RA   Cho J., King J.S., Qian X., Harwood A.J., Shears S.B.;
RT   "Dephosphorylation of 2,3-bisphosphoglycerate by MIPP expands the
RT   regulatory capacity of the Rapoport-Luebering glycolytic shunt.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:5998-6003(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Acts as a phosphoinositide 5- and phosphoinositide 6-
CC       phosphatase and regulates cellular levels of inositol
CC       pentakisphosphate (InsP5) and inositol hexakisphosphate (InsP6).
CC       Also acts as a 2,3-bisphosphoglycerate 3-phosphatase, by mediating
CC       the dephosphorylation of 2,3-bisphosphoglycerate (2,3-BPG) to
CC       produce phospho-D-glycerate without formation of 3-
CC       phosphoglycerate. May play a role in bone development
CC       (endochondral ossification). May play a role in the transition of
CC       chondrocytes from proliferation to hypertrophy (By similarity).
CC       {ECO:0000250|UniProtKB:F1NPQ2, ECO:0000269|PubMed:18413611}.
CC   -!- CATALYTIC ACTIVITY: Myo-inositol hexakisphosphate + H(2)O = myo-
CC       inositol pentakisphosphate (mixed isomers) + phosphate.
CC       {ECO:0000269|PubMed:18413611}.
CC   -!- CATALYTIC ACTIVITY: 2,3-bisphospho-D-glycerate + H(2)O = 2-
CC       phospho-D-glycerate + phosphate. {ECO:0000269|PubMed:18413611}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.61 mM for 2,3-bisphosphoglycerate
CC         {ECO:0000269|PubMed:18413611};
CC         KM=90 uM for inositol hexakisphosphate
CC         {ECO:0000269|PubMed:16759730};
CC         Vmax=15.8 nmol/min/mg enzyme with 2,3-bisphospho-D-glycerate as
CC         substrate {ECO:0000269|PubMed:18413611};
CC         Vmax=6.2 nmol/min/mg enzyme with inositol hexakisphosphate as
CC         substrate {ECO:0000269|PubMed:16759730};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen
CC       {ECO:0000250|UniProtKB:O35217}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9UNW1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UNW1-2; Sequence=VSP_014552, VSP_014555;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q9UNW1-3; Sequence=VSP_014553, VSP_014554;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q9UNW1-4; Sequence=VSP_044569;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in
CC       kidney, liver and placenta. {ECO:0000269|PubMed:9923613}.
CC   -!- DISEASE: Thyroid cancer, non-medullary, 2 (NMTC2) [MIM:188470]: A
CC       form of non-medullary thyroid cancer (NMTC), a cancer
CC       characterized by tumors originating from the thyroid follicular
CC       cells. NMTCs represent approximately 95% of all cases of thyroid
CC       cancer and are classified into papillary, follicular, Hurthle
CC       cell, and anaplastic neoplasms. {ECO:0000269|PubMed:11297621}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the histidine acid phosphatase family.
CC       MINPP1 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD93056.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF084943; AAD09751.1; -; mRNA.
DR   EMBL; AF084944; AAD09752.1; -; mRNA.
DR   EMBL; AF046914; AAD02437.1; -; mRNA.
DR   EMBL; AL050356; CAB43673.1; -; mRNA.
DR   EMBL; AY358938; AAQ89297.1; -; mRNA.
DR   EMBL; AK309176; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AB209819; BAD93056.1; ALT_INIT; mRNA.
DR   EMBL; AL355334; CAH73423.1; -; Genomic_DNA.
DR   EMBL; AL138767; CAH73423.1; JOINED; Genomic_DNA.
DR   EMBL; AL138767; CAI16030.1; -; Genomic_DNA.
DR   EMBL; AL355334; CAI16030.1; JOINED; Genomic_DNA.
DR   EMBL; AL355334; CAH73422.1; -; Genomic_DNA.
DR   EMBL; AL138767; CAH73422.1; JOINED; Genomic_DNA.
DR   EMBL; AL138767; CAI16029.1; -; Genomic_DNA.
DR   EMBL; AL355334; CAI16029.1; JOINED; Genomic_DNA.
DR   EMBL; BC032504; AAH32504.1; -; mRNA.
DR   CCDS; CCDS53551.1; -. [Q9UNW1-2]
DR   CCDS; CCDS53552.1; -. [Q9UNW1-4]
DR   CCDS; CCDS7384.1; -. [Q9UNW1-1]
DR   RefSeq; NP_001171588.1; NM_001178117.1. [Q9UNW1-2]
DR   RefSeq; NP_001171589.1; NM_001178118.1. [Q9UNW1-4]
DR   RefSeq; NP_004888.2; NM_004897.4. [Q9UNW1-1]
DR   RefSeq; XP_011538681.1; XM_011540379.2. [Q9UNW1-4]
DR   RefSeq; XP_016872455.1; XM_017016966.1. [Q9UNW1-4]
DR   UniGene; Hs.121260; -.
DR   ProteinModelPortal; Q9UNW1; -.
DR   BioGrid; 114932; 16.
DR   IntAct; Q9UNW1; 2.
DR   STRING; 9606.ENSP00000361064; -.
DR   DEPOD; Q9UNW1; -.
DR   iPTMnet; Q9UNW1; -.
DR   PhosphoSitePlus; Q9UNW1; -.
DR   BioMuta; MINPP1; -.
DR   DMDM; 68565617; -.
DR   EPD; Q9UNW1; -.
DR   PaxDb; Q9UNW1; -.
DR   PeptideAtlas; Q9UNW1; -.
DR   PRIDE; Q9UNW1; -.
DR   DNASU; 9562; -.
DR   Ensembl; ENST00000371994; ENSP00000361062; ENSG00000107789. [Q9UNW1-2]
DR   Ensembl; ENST00000371996; ENSP00000361064; ENSG00000107789. [Q9UNW1-1]
DR   Ensembl; ENST00000536010; ENSP00000437823; ENSG00000107789. [Q9UNW1-4]
DR   GeneID; 9562; -.
DR   KEGG; hsa:9562; -.
DR   UCSC; uc001keu.4; human. [Q9UNW1-1]
DR   CTD; 9562; -.
DR   DisGeNET; 9562; -.
DR   GeneCards; MINPP1; -.
DR   HGNC; HGNC:7102; MINPP1.
DR   HPA; HPA026859; -.
DR   MalaCards; MINPP1; -.
DR   MIM; 188470; phenotype.
DR   MIM; 605391; gene.
DR   neXtProt; NX_Q9UNW1; -.
DR   OpenTargets; ENSG00000107789; -.
DR   PharmGKB; PA30820; -.
DR   eggNOG; KOG1382; Eukaryota.
DR   eggNOG; ENOG4111FS8; LUCA.
DR   GeneTree; ENSGT00390000018409; -.
DR   HOGENOM; HOG000113591; -.
DR   HOVERGEN; HBG052872; -.
DR   InParanoid; Q9UNW1; -.
DR   KO; K03103; -.
DR   OMA; TRYEDAN; -.
DR   OrthoDB; EOG091G0FRE; -.
DR   PhylomeDB; Q9UNW1; -.
DR   TreeFam; TF324072; -.
DR   BioCyc; MetaCyc:HS03025-MONOMER; -.
DR   BRENDA; 3.1.3.62; 2681.
DR   Reactome; R-HSA-1855231; Synthesis of IPs in the ER lumen.
DR   SABIO-RK; Q9UNW1; -.
DR   ChiTaRS; MINPP1; human.
DR   GeneWiki; MINPP1; -.
DR   GenomeRNAi; 9562; -.
DR   PRO; PR:Q9UNW1; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000107789; -.
DR   CleanEx; HS_MINPP1; -.
DR   Genevisible; Q9UNW1; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0003993; F:acid phosphatase activity; IBA:GO_Central.
DR   GO; GO:0034417; F:bisphosphoglycerate 3-phosphatase activity; IDA:BHF-UCL.
DR   GO; GO:0052826; F:inositol hexakisphosphate 2-phosphatase activity; TAS:Reactome.
DR   GO; GO:0052745; F:inositol phosphate phosphatase activity; IBA:GO_Central.
DR   GO; GO:0030351; F:inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity; TAS:Reactome.
DR   GO; GO:0051717; F:inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity; TAS:Reactome.
DR   GO; GO:0008969; F:phosphohistidine phosphatase activity; TAS:ProtInc.
DR   GO; GO:0030282; P:bone mineralization; NAS:UniProtKB.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   GO; GO:0001503; P:ossification; NAS:UniProtKB.
DR   GO; GO:0006797; P:polyphosphate metabolic process; TAS:ProtInc.
DR   CDD; cd07061; HP_HAP_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR000560; His_Pase_clade-2.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   InterPro; IPR016274; Histidine_acid_Pase_euk.
DR   Pfam; PF00328; His_Phos_2; 1.
DR   PIRSF; PIRSF000894; Acid_phosphatase; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
DR   PROSITE; PS00014; ER_TARGET; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Disease mutation;
KW   Endoplasmic reticulum; Glycoprotein; Hydrolase; Polymorphism;
KW   Reference proteome; Signal.
FT   SIGNAL        1     30       {ECO:0000250}.
FT   CHAIN        31    487       Multiple inositol polyphosphate
FT                                phosphatase 1.
FT                                /FTId=PRO_0000019582.
FT   MOTIF       484    487       Prevents secretion from ER.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10138}.
FT   ACT_SITE     89     89       {ECO:0000250|UniProtKB:Q9Z2L6}.
FT   CARBOHYD    242    242       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:16335952}.
FT   CARBOHYD    481    481       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    213       MLRAPGCLLRTSVAPAAALAAALLSSLARCSLLEPRDPVAS
FT                                SLSPYFGTKTRYEDVNPVLLSGPEAPWRDPELLEGTCTPVQ
FT                                LVALIRHGTRYPTVKQIRKLRQLHGLLQARGSRDGGASSTG
FT                                SRDLGAALADWPLWYADWMDGQLVEKGRQDMRQLALRLASL
FT                                FPALFSRENYGRLRLITSSKHRCMDSSAAFLQGLWQHYHPG
FT                                LPPPDVAD -> MCLFQLCGLVRY (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_044569.
FT   VAR_SEQ     279    312       DLIQVAFFTCSFDLAIKGVKSPWCDVFDIDDAKV -> GLS
FT                                QFLLQSSSSLVMQRLFFHCFLSWATSKTRNP (in
FT                                isoform 2). {ECO:0000303|PubMed:9923613}.
FT                                /FTId=VSP_014552.
FT   VAR_SEQ     279    284       DLIQVA -> GIRIFK (in isoform 3).
FT                                {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_014553.
FT   VAR_SEQ     285    487       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_014554.
FT   VAR_SEQ     313    487       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9923613}.
FT                                /FTId=VSP_014555.
FT   VARIANT      41     41       S -> L (in NMTC2; somatic mutation;
FT                                dbSNP:rs119486096).
FT                                {ECO:0000269|PubMed:11297621}.
FT                                /FTId=VAR_022836.
FT   VARIANT     270    270       Q -> R (in NMTC2; dbSNP:rs104894171).
FT                                {ECO:0000269|PubMed:11297621}.
FT                                /FTId=VAR_022837.
FT   MUTAGEN      89     89       H->A: Strong reduction of 2,3-
FT                                bisphosphoglycerate 3-phosphatase
FT                                activity. {ECO:0000269|PubMed:18413611}.
FT   MUTAGEN     370    370       H->A: Greatly diminishes phosphatase
FT                                activity. {ECO:0000269|PubMed:9923613}.
FT   CONFLICT     81     81       V -> A (in Ref. 3; CAB43673).
FT                                {ECO:0000305}.
FT   CONFLICT    111    111       A -> P (in Ref. 2; AAD02437).
FT                                {ECO:0000305}.
FT   CONFLICT    132    132       A -> R (in Ref. 2; AAD02437).
FT                                {ECO:0000305}.
FT   CONFLICT    156    157       QL -> HV (in Ref. 2; AAD02437).
FT                                {ECO:0000305}.
FT   CONFLICT    344    344       F -> S (in Ref. 3; CAB43673).
FT                                {ECO:0000305}.
SQ   SEQUENCE   487 AA;  55051 MW;  89B8F347885B320A CRC64;
     MLRAPGCLLR TSVAPAAALA AALLSSLARC SLLEPRDPVA SSLSPYFGTK TRYEDVNPVL
     LSGPEAPWRD PELLEGTCTP VQLVALIRHG TRYPTVKQIR KLRQLHGLLQ ARGSRDGGAS
     STGSRDLGAA LADWPLWYAD WMDGQLVEKG RQDMRQLALR LASLFPALFS RENYGRLRLI
     TSSKHRCMDS SAAFLQGLWQ HYHPGLPPPD VADMEFGPPT VNDKLMRFFD HCEKFLTEVE
     KNATALYHVE AFKTGPEMQN ILKKVAATLQ VPVNDLNADL IQVAFFTCSF DLAIKGVKSP
     WCDVFDIDDA KVLEYLNDLK QYWKRGYGYT INSRSSCTLF QDIFQHLDKA VEQKQRSQPI
     SSPVILQFGH AETLLPLLSL MGYFKDKEPL TAYNYKKQMH RKFRSGLIVP YASNLIFVLY
     HCENAKTPKE QFRVQMLLNE KVLPLAYSQE TVSFYEDLKN HYKDILQSCQ TSEECELARA
     NSTSDEL
//
